Authors
Loading...
Distinguishes FHD from Tangier disease in low-HDL families; leaves open whether HDL subspecies guide risk stratification or therapy.
Key points are not available for this paper at this time.
Marcil et al. (1999) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: